REVIEW
|
doi:10.20944/preprints202409.0678.v1
Subject:
Oncology And Oncogenics,
Medicine And Pharmacology
Keywords:
Malignant Lymphomas; Hodgkin Lymphomas (HL); Non-Hodgkin Lymphomas (NHL); B-cell Neoplasms; T-cell Neoplasms; NK-cell Neoplasms; Grey Zone Lymphomas; Epidemiology; Classification; Staging; Histopathology; Radiotherapy; Chemotherapy; Immunotherapy; Treatment Strategies; Remission; Treatment Complications; Personalized Medicine; Innovative Therapies
Online: 9 September 2024 (11:58:11 CEST)
ARTICLE
|
doi:10.20944/preprints202409.0628.v1
Subject:
Oncology And Oncogenics,
Medicine And Pharmacology
Keywords:
Hodgkin Lymphoma (HL); Non-Hodgkin Lymphoma (NHL); malignant lymphomas; genetic factors; environmental carcinogenic factors; multifactorial disorders; hereditary
Online: 9 September 2024 (09:21:15 CEST)